3-METHYLCYCLOPENTANE-1-CARBOXYLIC ACID, 95.0%, 250mg

(E)-Methyl 2-(2-(((1,3-dioxoisoindolin-2-yl)oxy)methyl)phenyl)-2-(methoxyimino)acetate, 97.0%, 1g

3-Méthoxy-3-méthyl-1-butanol, min.99%, pour la synthèse, 500 ml, emballage en verre

Methyl 2-bromo-5-methylthiazole-4-carboxylate, 95.0%, 100mg

5-Amino-1-(2,3-dichloro-phenyl)-1H-pyrazole-4-carbonitrile, 95.0%, 1g

4-Nitro-3-(trifluoromethyl)benzenesulfonylchloride, 97.0%, 1g

3-Hydroxyadamantan-1-yl methacrylate, 95.0%, 100g

2-Chloro-6-methoxyquinoxaline, 95.0%, 1g

Methyl 1-phenylcyclopropane-1-carboxylate, 97%, 5g

2-(((3aR,4S,6R,6aS)-6-((5-Amino-6-chloro-2-(propylthio)pyrimidin-4-yl)amino)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol, 98%, 25g

2-[(4,6-dimethylpyrimidin-2-yl)sulfanyl]acetohydrazide, 97%, 100mg

Tetradecan-2-one, 95.0%, 10g

(1-(Tert-butyldimethylsilyl)-1H-indol-4-yl)boronic acid, 98+%, 1g